Insider Trading Alert - BID, WWWW And BKU Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 17, 2014, 130 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $559.00 to $22,026,172.00.

Highlighted Stocks Traded by Insiders:

Sothebys (BID) - FREE Research Report

De Sole Domenico who is Director at Sothebys bought 4,000 shares at $45.05 on March 17, 2014. Following this transaction, the Director owned 4,000 shares meaning that the stake was reduced by 100% with the 4,000-share transaction.

The shares most recently traded at $48.06, up $3.01, or 6.26% since the insider transaction. Historical insider transactions for Sothebys go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 6,888
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 6,888
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 7,099

The average volume for Sothebys has been 1.3 million shares per day over the past 30 days. Sothebys has a market cap of $3.2 billion and is part of the services sector and specialty retail industry. Shares are down 11.79% year-to-date as of the close of trading on Friday.

Sotheby's operates as an auctioneer of authenticated fine art, decorative art, and jewelry. The company operates in three segments: Auction, Finance, and Dealer. The stock currently has a dividend yield of 0.85%. The company has a P/E ratio of 25.0. Currently there are 2 analysts that rate Sothebys a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on BID - FREE

TheStreet Quant Ratings rates Sothebys as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Sothebys Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Web.com Group (WWWW) - FREE Research Report

Levy Anton J who is Director at Web.com Group sold 50,000 shares at $37.05 on March 17, 2014. Following this transaction, the Director owned 1.8 million shares meaning that the stake was reduced by 2.77% with the 50,000-share transaction.

The shares most recently traded at $36.17, down $0.88, or 2.43% since the insider transaction. Historical insider transactions for Web.com Group go as follows:

  • 12-Week # shares sold: 20,000
  • 24-Week # shares sold: 20,000

The average volume for Web.com Group has been 584,800 shares per day over the past 30 days. Web.com Group has a market cap of $1.9 billion and is part of the technology sector and internet industry. Shares are up 16.51% year-to-date as of the close of trading on Friday.

Web.com Group, Inc. provides Internet services to small businesses in North America, South America, and the United Kingdom. The company offers a range of Web services and products that enable small businesses to establish, maintain, promote, and optimize their online presence. Currently there are 8 analysts that rate Web.com Group a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WWWW - FREE

TheStreet Quant Ratings rates Web.com Group as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Web.com Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BankUnited (BKU) - FREE Research Report

Lunak Leslie who is Chief Financial Officer at BankUnited sold 1,101 shares at $33.60 on March 17, 2014. Following this transaction, the Chief Financial Officer owned 45,899 shares meaning that the stake was reduced by 2.34% with the 1,101-share transaction.

The shares most recently traded at $33.86, up $0.26, or 0.77% since the insider transaction.

The average volume for BankUnited has been 757,000 shares per day over the past 30 days. BankUnited has a market cap of $3.4 billion and is part of the financial sector and banking industry. Shares are up 2.82% year-to-date as of the close of trading on Friday.

BankUnited, Inc., a bank holding company, provides a range of banking products and financial services to commercial and middle-market businesses, and individual customers in the United States. The stock currently has a dividend yield of 2.48%. The company has a P/E ratio of 16.8. Currently there are 3 analysts that rate BankUnited a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BKU - FREE

TheStreet Quant Ratings rates BankUnited as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and premium valuation. Get the full BankUnited Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing